Concepedia

Stacy S. Shord

SS

36

Publications

3.2K

Citations

27

H-Index

2000

Active since

Affiliations

United States Food and Drug Administration(Current)

Center for Drug Evaluation and Research

University of Illinois Chicago

University of North Carolina at Chapel Hill

IS practice

Stacy S. Shord is an author at United States Food and Drug Administration specializing in medicine, pharmacology, and pharmacotherapy.

ORCID

Top concepts

Publications per year

2000–2025

36

Publications

36

FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell-Induced Severe or Life-Threatening Cytokine Release Syndrome

Robert Q. Le, Liang Li, Weishi Yuan et al. · The Oncologist · 2018 · 859 citations · Full text

Validation of Bupropion Hydroxylation as a Selective Marker of Human Cytochrome P450 2B6 Catalytic Activity

Stephanie Faucette, Roy L. Hawke, Edward L. LeCluyse et al. · Drug Metabolism and Disposition · 2000 · 355 citations

FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemia

Aviva C. Krauss, Xin Gao, Liang Li et al. · Clinical Cancer Research · 2018 · 315 citations · Full text

Bioanalysis of Antibody–Drug Conjugates: American Association of Pharmaceutical Scientists Antibody–Drug Conjugate Working Group Position Paper

Boris Gorovits, Stephen C. Alley, Sanela Bilic et al. · Bioanalysis · 2013 · 164 citations

, , +17

FDA Approval Summary: Sonidegib for Locally Advanced Basal Cell Carcinoma

Denise Casey, Suzanne Demko, Stacy S. Shord et al. · Clinical Cancer Research · 2017 · 125 citations · Full text

Rows per page

1–5 of 36